John W. Davis

8.1k total citations · 1 hit paper
190 papers, 4.2k citations indexed

About

John W. Davis is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, John W. Davis has authored 190 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Pulmonary and Respiratory Medicine, 44 papers in Surgery and 26 papers in Urology. Recurrent topics in John W. Davis's work include Prostate Cancer Diagnosis and Treatment (96 papers), Prostate Cancer Treatment and Research (84 papers) and Bladder and Urothelial Cancer Treatments (19 papers). John W. Davis is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (96 papers), Prostate Cancer Treatment and Research (84 papers) and Bladder and Urothelial Cancer Treatments (19 papers). John W. Davis collaborates with scholars based in United States, Canada and China. John W. Davis's co-authors include Paul F. Schellhammer, John P. Vanden Heuvel, Deborah A. Kuban, Louis L. Pisters, Patricia Troncoso, Donald F. Lynch, Jeri Kim, R. Joseph Babaian, John F. Ward and Eric Tien and has published in prestigious journals such as Journal of the American Chemical Society, JAMA and Journal of Biological Chemistry.

In The Last Decade

John W. Davis

186 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

2022 124 citations John W. Davis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John W. Davis United States	37	2.4k	953	812	699	509	190	4.2k
Daniel M. Moreira United States	34	2.8k 1.2×	710 0.7×	840 1.0×	717 1.0×	604 1.2×	184	3.7k
Swen‐Olof Andersson Sweden	34	3.4k 1.4×	1.3k 1.4×	698 0.9×	1.3k 1.8×	596 1.2×	59	5.6k
Jeffrey M. Slezak United States	40	3.2k 1.4×	1.2k 1.3×	592 0.7×	595 0.9×	705 1.4×	99	5.2k
Wade J. Sexton United States	32	2.1k 0.9×	1.7k 1.8×	858 1.1×	860 1.2×	330 0.6×	194	4.2k
Richard J. Babaian United States	37	2.8k 1.2×	1.1k 1.2×	595 0.7×	852 1.2×	387 0.8×	88	4.4k
Karl Pummer Austria	37	2.0k 0.9×	1.2k 1.3×	1.0k 1.3×	1.0k 1.5×	815 1.6×	156	4.1k
Jianbo Li United States	35	2.4k 1.0×	1.0k 1.1×	772 1.0×	300 0.4×	446 0.9×	187	4.5k
Jonathan L. Wright United States	39	2.0k 0.8×	2.1k 2.2×	1.1k 1.3×	826 1.2×	620 1.2×	255	5.0k
Leon Sun United States	44	4.4k 1.8×	1.1k 1.2×	930 1.1×	1.0k 1.5×	802 1.6×	147	6.2k
Julio M. Pow‐Sang United States	38	1.3k 0.5×	1.7k 1.8×	1.1k 1.3×	1.3k 1.8×	506 1.0×	214	4.7k

Countries citing papers authored by John W. Davis

Since Specialization

Citations

This map shows the geographic impact of John W. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Davis more than expected).

Fields of papers citing papers by John W. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Davis. The network helps show where John W. Davis may publish in the future.

Co-authorship network of co-authors of John W. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Davis. A scholar is included among the top collaborators of John W. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Davis. John W. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davis, John W., et al.. (2024). Bicarbonate and Serum Lab Markers as Predictors of Mortality in the Trauma Patient. Western Journal of Emergency Medicine. 25(4). 661–667. 2 indexed citations

Wilkins, Lamont, Jeffrey J. Tosoian, Chad A. Reichard, et al.. (2021). Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8‐10) prostate cancer treated primarily by radical prostatectomy. Cancer. 127(9). 1425–1431. 8 indexed citations

Davis, John W., Amado J. Zurita, Xuemei Wang, et al.. (2021). Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer. European Journal of Cancer. 157. 259–267. 12 indexed citations

Ranasinghe, Weranja, Daniel D. Shapiro, Miao Zhang, et al.. (2021). Optimizing the diagnosis and management of ductal prostate cancer. Nature Reviews Urology. 18(6). 337–358. 22 indexed citations

Gregg, Justin R., Leonardo D. Borregales, Haesun Choi, et al.. (2021). Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World Journal of Urology. 39(9). 3259–3264. 6 indexed citations

Chapin, Brian F., et al.. (2021). Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase. Urology. 155. 144–151. 1 indexed citations

Vykoukal, Jody V., Johannes F. Fahrmann, Justin R. Gregg, et al.. (2020). Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer. Nature Communications. 11(1). 4279–4279. 50 indexed citations

Ranasinghe, Weranja, Daniel D. Shapiro, Hyunsoo Hwang, et al.. (2020). Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies. European Urology. 79(2). 298–306. 29 indexed citations

Hoffman, Richard M., Robert J. Volk, Brian F. Chapin, et al.. (2019). Impact of Multidisciplinary Counseling on Awareness of Prostate Cancer Treatment Options. International Journal of Radiation Oncology*Biology*Physics. 105(1). E442–E442. 1 indexed citations

10.

Demi̇rel, Hüseyi̇n & John W. Davis. (2018). Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions. SHILAP Revista de lepidopterología. 44(2). 93–102. 26 indexed citations

11.

Zargar, Homayoun, Alastair Lamb, Bernardo Rocco, et al.. (2016). Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis. Minerva Urology and Nephrology. 69(1). 26–37. 28 indexed citations

12.

Zhang, Tao, Chieh Tseng, Yan Zhang, et al.. (2016). CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nature Communications. 7(1). 11674–11674. 136 indexed citations

13.

Williams, Stephen B., John W. Davis, Xuemei Wang, et al.. (2015). Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clinical Genitourinary Cancer. 14(2). 130–138. 14 indexed citations

14.

Davis, John W., et al.. (2013). Learning Curve Assessment of Robot-Assisted Radical Prostatectomy Compared with Open-Surgery Controls from the Premier Perspective Database. Journal of Endourology. 28(5). 560–566. 39 indexed citations

15.

Davis, John W., Mary Achim, Mark F. Munsell, & Surena F. Matin. (2011). Effectiveness of Postgraduate Training for Learning Extraperitoneal Access for Robot-Assisted Radical Prostatectomy. Journal of Endourology. 25(8). 1363–1369. 13 indexed citations

16.

Nakanishi, Hiroyuki, Xuemei Wang, Atsushi Ochiai, et al.. (2007). A nomogram for predicting low‐volume/low‐grade prostate cancer. Cancer. 110(11). 2441–2447. 55 indexed citations

17.

Heijde, D. van der, et al.. (2005). Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.. Oxford University Research Archive (ORA) (University of Oxford). 52(9). 4 indexed citations

18.

Davis, John W., Serdar Değer, Jan Roigas, et al.. (2003). Positive Margins after Laparoscopic Radical Prostatectomy: A Prospective Study of 100 Cases Performed by 4 Different Surgeons. European Urology. 43(6). 622–626. 30 indexed citations

19.

Türk, I., Serdar Değer, William R. Morgan, et al.. (2002). Sural nerve graft during laparoscopic radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 7(5). 191–194. 12 indexed citations

20.

Heuvel, John P. Vanden, et al.. (1992). Renal excretion of perfluorooctanoic acid in male rats: Inhibitory effect of testosterone. Journal of Biochemical Toxicology. 7(1). 31–36. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact